4526 — Riken Vitamin Co Income Statement

0.000.00%

Last trade - 00:00

Consumer DefensivesConservativeMid CapSuper Stock

Annual income statement for Riken Vitamin Co, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.

	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Yuho	Yuho	Yuho	Yuho	Yuho
Standards:	JAS	JAS	JAS	JAS	JAS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	77,722	79,231	88,750	91,484	95,582
Cost of Revenue
Gross Profit	22,011	25,565	27,244	29,886	31,270
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	78,546	73,651	81,642	82,618	87,920
Operating Profit	-824	5,580	7,108	8,866	7,662
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-7	20,313	7,857	11,909	12,706
Provision for Income Taxes
Net Income After Taxes	-1,610	21,598	6,417	8,760	9,392
Minority Interest
Net Income Before Extraordinary Items
Net Income	-1,618	21,582	6,414	8,757	9,389
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	-1,618	21,582	6,414	8,755	9,388
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-5.83	663	197	280	329
Dividends per Share